Latest / Odessa News Today | 2 Min News | The Daily News Now!
Breakthrough Drug Extends Pancreatic Cancer Survival | Odessa News
FDA just approved a game-changing pill for advanced pancreatic cancer—Rasonque, which slashes median survival from 6.7 to 13.2 months and offers far fewer side effects. Targeting the long-elusive KRAS mutation, this “undruggable” protein breakthrough could reshape cancer treatment across multiple cancers, with Revolutions Medicines already eyeing lung cancer next. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.